2020年利伐沙班的最新价格

As an anticoagulant, it is mainly used to prevent or treat blood clots and prevent them from growing again. It cannot completely remove blood clots. Because the human body has a coagulation system and a hemolysis system. As long as the thrombus does not increase further, the body's hemolysis system will activate and have a certain effect on removing the thrombus. So what is the latest price of rivaroxaban in 2020?

Price of rivaroxaban: Domestic rivaroxaban is the original drug produced by Bayer Pharma AG/Germany Bayer Pharmaceuticals. Specification: 10mg-5 tablets/box, priced at about 138$; Specification: 15mg-7 tablets/box, priced at about 199$; Specification: 20mg-7 tablets/box, priced at about 263$.

The specifications of rivaroxaban available abroad are 15mg*28 tablets; the price of 20mg*28 tablets is around $600. For specific and detailed prices, you can consult Medical Companion Travel at any time! In terms of purchase, patients can go abroad to purchase from pharmacies or obtain them through domestic professional overseas medical service organizations (such as Medical Companion Travel).

Precautions when using rivaroxaban:

1. Bleeding risk: As detailed below, some subgroups of patients are at higher risk of bleeding. After initiation of treatment, these patients should be monitored closely for signs of bleeding complications. This can be accomplished by regular physical examination of the patient, close observation of surgical wound drainage, and regular determination of hemoglobin. Any unexplained decrease in hemoglobin or blood pressure should prompt a search for the site of bleeding.

2. Renal damage: In patients with severe renal impairment (creatinine clearance <30 mL/min), the blood concentration of the drug may increase significantly, leading to an increased risk of bleeding. Rivaroxaban is not recommended for patients with creatinine clearance <15 mL/min. Rivaroxaban should be used with caution in patients with creatinine clearance 15-29 mL/min. Rivaroxaban should be used with caution in patients with moderate renal impairment (creatinine clearance 30-49 mL/min) when used concomitantly with other drugs that may increase rivaroxaban plasma concentrations.